Tearsheet
Investment Highlights Market Valuation Price Chart Business Description Interactive Breakdown Latest Trefis Analyses Better Bets vs. CELH Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Celsius (CELH)

Market Price (9/18/2025): $56.51 | Market Cap: $14.6 Bil
Sector: Consumer Staples | Industry: Soft Drinks & Non-alcoholic Beverages

Celsius (CELH)

Market Price (9/18/2025): $56.51
Market Cap: $14.6 Bil
Sector: Consumer Staples
Industry: Soft Drinks & Non-alcoholic Beverages

Investment Highlights

0 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 12%		 Weak multi-year price returns
2Y Excs Rtn is -63%, 3Y Excs Rtn is -3.1%		 Expensive valuation multiples
P/SPrice/Sales ratio is 8.7x, P/EBITPrice/EBIT or Price/(Operating Income) ratio is 82x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 62x, P/EPrice/Earnings or Price/(Net Income) is 110x
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 14%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 13%		  Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 57%
2   Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3.6%
0 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 12%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 14%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 13%
2 Weak multi-year price returns
2Y Excs Rtn is -63%, 3Y Excs Rtn is -3.1%
3 Expensive valuation multiples
P/SPrice/Sales ratio is 8.7x, P/EBITPrice/EBIT or Price/(Operating Income) ratio is 82x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 62x, P/EPrice/Earnings or Price/(Net Income) is 110x
4 Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 57%
5 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3.6%

Market Valuation

 9/18/252024202320222021
Share Price CYE$56.51$26.34$54.52$34.68$24.86
Market Cap CYE ($ Bil)14.66.212.67.95.5
Total Debt ($ Bil)0.90.00.00.00.0
Total Cash ($ Bil)0.60.90.80.60.0
Enterprise Value ($ Bil)14.86.212.67.95.5
Valuation Ratios     
P/S TTM8.74.59.612.017.5
P/EBIT TTM81.939.547.2-49.9-1358.2
P/E TTM110.542.455.5-42.01397.5
Sector Ratios     
P/S TTM (Sector)0.90.90.90.91.6
P/EBIT TTM (Sector)8.48.910.09.411.6
P/E TTM (Sector)12.612.114.011.616.2
 9/18/2520242023
Share Price CYE$56.51$26.34$54.52
Market Cap CYE ($ Bil)14.66.212.6
Total Debt ($ Bil)0.90.00.0
Total Cash ($ Bil)0.60.90.8
Enterprise Value ($ Bil)14.86.212.6
Valuation Ratios   
P/S TTM8.74.59.6
P/EBIT TTM81.939.547.2
P/E TTM110.542.455.5
Sector Ratios   
P/S TTM (Sector)0.90.90.9
P/EBIT TTM (Sector)8.48.910.0
P/E TTM (Sector)12.612.114.0

Market Cap Chart

Business Description

Celsius Holdings, Inc. develops, processes, markets, distributes, and sells functional drinks and liquid supplements in North America, Europe, Asia, and internationally. It offers various carbonated and non-carbonated functional energy drinks under the CELSIUS Originals name; dietary supplement in carbonated flavors, including apple jack'd, orangesicle, inferno punch, cherry lime, blueberry pomegranate, strawberry dragon fruit, tangerine grapefruit, and jackfruit under the CELSIUS HEAT name; and branched-chain amino acids functional energy drink that fuels muscle recovery under the CELSIUS BCCA+ENERGY name. Show more

Price Returns Compared

Expand for Detailed View

 202020212022202320242025Total [1]
Returns
CELH Return942%48%40%57%-52%114%3491%
Peers Return203%20%12%12%-12%26%408%
S&P 500 Return16%27%-19%24%23%12%104%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: KO, PEP, MNST, KDP, CELH. See CELH Returns vs. Peers.
[3] 2025 data is for the year up to 9/17/2025 (YTD)

Better Bets than Celsius (CELH)

 CELHBetter Performance than CELH
MetricValueIndustry (Soft Drinks & Non-alcoholic Be)
Rev Chg LTM11.9%PRMB (26.3%), COCO (12.0%), BRFH (24.5%)
Rev Chg 3Y Avg54.7%SHOT (159.5%), BYLT (434.6%)
Op Mgn LTM10.4%KO (30.6%), PEP (13.5%), MNST (26.9%), KDP (21.5%), COKE (13.1%)
CFO/Rev LTM14.1%MNST (26.8%), FIZZ (17.2%)
FCF/Rev LTM12.7%MNST (23.5%), FIZZ (14.2%)
Total Yield0.9%KO (7.2%), PEP (7.8%), MNST (2.4%), KDP (5.8%), COKE (6.4%)
 CELHBetter Performance than CELH
MetricValueAll Other Sectors
Rev Chg LTM11.9%NVDA (71.6%), MSFT (14.9%), GOOGL (13.1%), META (19.4%), AVGO (28.0%)
Rev Chg 3Y Avg54.7%NVDA (92.0%), RCL (65.4%), APO (129.8%), NU (70.1%), CCL (81.1%)
Op Mgn LTM10.4%NVDA (58.1%), MSFT (45.6%), AAPL (31.9%), GOOGL (32.7%), AMZN (11.4%)
CFO/Rev LTM14.1%NVDA (46.6%), MSFT (48.3%), AAPL (26.6%), GOOGL (36.0%), AMZN (18.1%)
FCF/Rev LTM12.7%NVDA (43.6%), MSFT (25.4%), AAPL (23.5%), GOOGL (18.0%), META (30.7%)
Total Yield0.9%NVDA (2.1%), MSFT (3.3%), AAPL (3.2%), GOOGL (4.1%), AMZN (2.9%)

Latest Trefis Analyses

TitleTopicDate
0DASHBOARDS  
1Celsius Earnings Notes  
2With CELH Up 10% in a Week, Is It Time to Compare It Against RCL?Counter-Intuitive Comparisons 
3CELH's One-Week Rally Offers a Chance to Reevaluate CALMCounter-Intuitive Comparisons 
4Day 7 of Gains Streak for Celsius Stock with 34% Return (vs. 118% YTD) [8/15/2025]Notification 
5Day 6 of Gains Streak for Celsius Stock with 33% Return (vs. 115% YTD) [8/14/2025]Notification 
6How Does CELH Stack Up Against Its Peers?Peer Comparison 
7Better Bet Than CELH Stock: Pay Less Than Celsius To Get More From NVDA, RCL   
8Is CELH Stock Still the Best Pick Among Its Peers?  
9CELH Dip Buy Analysis  
10Celsius Total Shareholder Return (TSR): -51.7% in 2024 and 2.0% 3-yr compounded annual returns (above peer average)  
11ARTICLES  
12Mid Cap Stocks Trading At 52-Week High August 16th, 2025
13CELH Stock Up 34% after 7-Day Win Streak August 16th, 2025
14CELH Stock Up 33% after 6-Day Win Streak August 15th, 2025
15Mid Cap Stocks Trading At 52-Week High August 13th, 2025
16Stacking Up CELH Against Its Peers – Is It Still a Buy? August 9th, 2025
Title
0DASHBOARDS
1Mid Cap Stocks Trading At 52-Week High
2CELH Stock Up 34% after 7-Day Win Streak
3CELH Stock Up 33% after 6-Day Win Streak
4Mid Cap Stocks Trading At 52-Week High
5Stacking Up CELH Against Its Peers – Is It Still a Buy?
6ARTICLES
7Celsius Earnings Notes
8With CELH Up 10% in a Week, Is It Time to Compare It Against RCL?
9CELH's One-Week Rally Offers a Chance to Reevaluate CALM
10Day 7 of Gains Streak for Celsius Stock with 34% Return (vs. 118% YTD) [8/15/2025]
11Day 6 of Gains Streak for Celsius Stock with 33% Return (vs. 115% YTD) [8/14/2025]
12How Does CELH Stack Up Against Its Peers?
13Better Bet Than CELH Stock: Pay Less Than Celsius To Get More From NVDA, RCL 
14Is CELH Stock Still the Best Pick Among Its Peers?
15CELH Dip Buy Analysis
16Celsius Total Shareholder Return (TSR): -51.7% in 2024 and 2.0% 3-yr compounded annual returns (above peer average)

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1ECDAECD Automotive Design3347.2%307.9%
2BDSXBiodesix1090.6%-79.7%
3CLSDClearside Biomedical987.7%-74.7%
4ATHAAthira Pharma892.1%544.3%
5SDOTSadot690.6%-79.9%
6ATCHAtlasClear684.9%-83.1%
7HSDTHelius Medical Technologies232.1%-95.5%
8CHEKCheck-Cap222.2%134.4%
9APLMApollomics197.8%89.1%
10SPRCSciSparc147.0%1141.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1CURXCuranex Pharmaceuticals-80.5%148.4%
2ATYRaTyr Pharma-80.4%-71.7%
3NAKAKindly MD-70.2% 
4BNGOBionano Genomics-64.0%-89.8%
5XAGELongevity Health-57.6%-86.1%
6FAASDigiAsia-55.4%-88.0%
7ASSTStrive-54.5%650.3%
8VCIGVCI Global-51.0%-98.9%
9REXREX American Resources-50.7%44.3%
10RBNERobin Energy-42.6% 

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical11931.7%11931.7%
2GIBOGIBO10714.0% 
3LNZALanzaTech Global8455.2%-86.3%
4GTIGraphjet Technology3998.4%-93.1%
5GWAVGreenwave Technology Solutions3582.8%-91.4%
6QMMMQMMM3409.6%8153.1%
7ECDAECD Automotive Design2715.2%307.9%
8OESXOrion Energy Systems1373.7%14.2%
9OPOceanPal1266.5%-95.6%
10BCTXBriaCell Therapeutics1032.4%-89.8%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1CJETChijet Motor-94.5%-96.0%
2STFSStar Fashion Culture-92.3%-97.9%
3ELPWElong Power-91.1%-76.9%
4NXTTNext Technology-90.1%-95.4%
5EPIXESSA Pharma-89.4%-8.9%
6NAKAKindly MD-88.1% 
7BINIBollinger Innovations-87.6%-100.0%
8JEM707 Cayman-87.4%-98.2%
9YAASYouxin Technology-83.3%-98.4%
10NEONNeonode-82.5%-51.0%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1ECDAECD Automotive Design3347.2%307.9%
2BDSXBiodesix1090.6%-79.7%
3CLSDClearside Biomedical987.7%-74.7%
4ATHAAthira Pharma892.1%544.3%
5SDOTSadot690.6%-79.9%
6ATCHAtlasClear684.9%-83.1%
7HSDTHelius Medical Technologies232.1%-95.5%
8CHEKCheck-Cap222.2%134.4%
9APLMApollomics197.8%89.1%
10SPRCSciSparc147.0%1141.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1CURXCuranex Pharmaceuticals-80.5%148.4%
2ATYRaTyr Pharma-80.4%-71.7%
3NAKAKindly MD-70.2% 
4BNGOBionano Genomics-64.0%-89.8%
5XAGELongevity Health-57.6%-86.1%
6FAASDigiAsia-55.4%-88.0%
7ASSTStrive-54.5%650.3%
8VCIGVCI Global-51.0%-98.9%
9REXREX American Resources-50.7%44.3%
10RBNERobin Energy-42.6% 

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Celsius

Financials

CELHKOPEPMNSTKDPMedian
NameCelsius Coca-ColaPepsiCo Monster .Keurig D. 
Mkt Price56.3467.04141.2366.5227.2666.52
Mkt Cap14.5288.5193.664.937.064.9
Rev LTM1,66647,06291,7487,65915,75915,759
Op Inc LTM17314,41812,3872,0633,3823,382
FCF LTM211-7227,0641,8041,5751,575
FCF 3Y Avg1855,9406,6081,5521,3861,552
CFO LTM2361,30112,1882,0542,1172,054
CFO 3Y Avg2067,82811,9581,7921,8951,895

Growth & Margins

CELHKOPEPMNSTKDPMedian
NameCelsius Coca-ColaPepsiCo Monster .Keurig D. 
Rev Chg LTM11.9%1.3%-0.3%3.7%4.6%3.7%
Rev Chg 3Y Avg54.7%4.5%4.0%8.5%5.9%5.9%
Rev Chg Q83.9%1.4%1.0%11.1%6.1%6.1%
QoQ Delta Rev Chg LTM25.4%0.4%0.2%2.8%1.6%1.6%
Op Mgn LTM10.4%30.6%13.5%26.9%21.5%21.5%
Op Mgn 3Y Avg8.5%29.4%13.8%27.1%21.5%21.5%
QoQ Delta Op Mgn LTM1.0%0.6%-0.5%0.6%-0.1%0.6%
CFO/Rev LTM14.1%2.8%13.3%26.8%13.4%13.4%
CFO/Rev 3Y Avg14.7%17.3%13.1%24.6%12.5%14.7%
FCF/Rev LTM12.7%-1.5%7.7%23.5%10.0%10.0%
FCF/Rev 3Y Avg13.2%13.1%7.2%21.4%9.2%13.1%

Valuation

CELHKOPEPMNSTKDPMedian
NameCelsius Coca-ColaPepsiCo Monster .Keurig D. 
Mkt Cap14.5288.5193.664.937.064.9
P/S8.76.12.18.52.36.1
P/EBIT81.617.218.631.313.718.6
P/E110.223.725.641.324.125.6
P/CFO61.6221.815.931.617.531.6
Total Yield0.9%7.2%7.8%2.4%5.8%5.8%
Dividend Yield0.0%2.9%3.9%0.0%1.7%1.7%
FCF Yield 3Y Avg1.5%2.2%3.1%2.7%3.1%2.7%
D/E0.10.20.30.00.50.2
Net D/E0.00.10.2-0.00.50.1

Returns

CELHKOPEPMNSTKDPMedian
NameCelsius Coca-ColaPepsiCo Monster .Keurig D. 
1M Rtn-7.9%-2.3%-4.6%3.7%-21.3%-4.6%
3M Rtn27.8%-2.4%10.5%5.3%-17.3%5.3%
6M Rtn76.6%-1.8%-2.7%17.1%-17.4%-1.8%
12M Rtn61.9%-3.8%-17.1%30.3%-25.3%-3.8%
3Y Rtn67.8%23.2%-6.9%52.5%-20.8%23.2%
1M Excs Rtn-10.3%-4.6%-7.0%1.4%-23.7%-7.0%
3M Excs Rtn17.3%-13.3%-0.0%-4.4%-26.8%-4.4%
6M Excs Rtn68.0%-19.5%-20.8%-0.4%-35.3%-19.5%
12M Excs Rtn49.9%-20.6%-34.6%13.5%-42.8%-20.6%
3Y Excs Rtn-3.1%-42.3%-71.2%-18.4%-85.1%-42.3%

Comparison Analyses

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q3
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/202312/31/20229/30/2022
Filing Date8/8/20255/6/20253/3/202511/6/20248/6/20245/7/20242/29/202411/7/20238/8/20235/9/20233/1/202311/9/2022
Key Financials Quarterly            
Total Revenue739329332266402356347385326260178188
Ebitda15755-16-11068460996645-32-147
Operating Income14352-18-3948359986545-33-148
Net Income10044-196807850845241-21-182
EPS0.330.15-0.10-0.000.290.280.170.300.180.14-0.13-0.82
Key Financials TTM            
Total Revenue TTM1,6661,3291,3561,3711,4901,4141,3181,149952780654580
Ebitda TTM194144173250349309270177-68-121-156-121
Operating Income TTM173125156233334305266175-71-123-158-122
Net Income TTM132112145214292263227155-110-153-187-154
Growth Rates Quarterly            
Total Revenue Growth83.9%-7.4%-4.4%-30.9%23.4%36.8%95.2%104.4%111.6%94.9%70.7%98.3%
EBITDA Growth47.7%-35.3%-126.8%-101.0%61.9%85.7%286.6%167.0%427.6%336.4%-1073.8%-1757.5%
Operating Income Growth51.7%-37.5%-131.4%-103.3%45.4%85.2%280.0%166.2%421.4%344.0%-1244.2%-1703.3%
Net Income Growth25.2%-42.9%-137.7%-92.4%54.9%88.7%336.1%146.2%462.4%517.3%-277.7%-1841.1%
Margins Quarterly            
EBITDA Margin21.2%16.6%-4.8%-0.4%26.4%23.7%17.3%25.6%20.1%17.5%-18.1%-78.1%
Operating Income Margin19.3%15.8%-5.6%-1.2%23.4%23.4%17.0%25.4%19.9%17.3%-18.4%-78.4%
Net Income Margin13.5%13.5%-5.7%2.4%19.8%21.9%14.4%21.8%15.8%15.9%-11.9%-96.6%
Cash & Debt            
Total Cash615977890904903879756760681595614592
Total Debt8632020622211111
Net Debt / (Cash)248-958-870-898-901-878-754-759-680-594-613-591
Cash Flows Quarterly            
FCF from Operations4410376134013559159-14-63129
Cash Flows TTM            
FCF from Operations TTM2362322631922702901417311185108126
Returns to Shareholders Quarterly            
Dividends000000000000
Share Repurchases1212-0-0-0-0-0-0-0-0
Return on Invested Capital (ROIC) Quarterly            
ROIC21.0%90.8%-29.7%-4.6%138.9%123.8%50.3%91.8%45.6%29.2%-20.1%-115.6%
Return on Invested Capital (ROIC) TTM            
ROIC TTM5.8%51.0%46.5%83.5%127.4%106.0%59.7%40.7%-16.8%-24.2%-32.2%-23.9%

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Single Segment1,31865431413175
Total1,31865431413175


Net Income by Segment
$ Mil20242023202220212020
Single Segment227-187   
Total227-187   


Price Behavior

CELH Betas & Captures as of 8/31/2025

 1M2M3M6M1Y3Y
Beta0.130.280.790.800.751.18
Up Beta-0.230.360.870.870.791.15
Down Beta6.343.963.130.880.711.32
Up Capture111%85%172%170%99%156%
Bmk +ve Days10223571142415
Stock +ve Days13233567117365
Down Capture-588%-378%-230%-4%68%103%
Bmk -ve Days11192754106334
Stock -ve Days7162556129383

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date8292025
Short Interest: Shares Quantity18,755,681
Short Interest: % Change Since 8152025-8.5%
Average Daily Volume6,132,934
Days-to-Cover Short Interest3.06
Basic Shares Quantity257,750,000
Short % of Basic Shares7.3%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
8/7/202517.3%31.2%36.6%
5/6/20254.8%10.1%18.3%
2/20/202527.8%1.8%29.0%
11/6/2024-5.3%-15.0%-12.1%
8/6/2024-2.3%-8.0%-21.7%
11/7/2023-1.5%-8.2%-13.1%
8/8/202320.4%27.5%43.2%
11/3/20222.6%-9.2%35.7%
...
SUMMARY STATS   
# Positive857
# Negative586
Median Positive9.8%27.5%35.7%
Median Negative-5.3%-11.3%-12.6%
Max Positive27.8%41.8%59.8%
Max Negative-14.7%-25.8%-35.1%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025808202510-Q 6/30/2025
3312025506202510-Q 3/31/2025
12312024303202510-K 12/31/2024
93020241106202410-Q 9/30/2024
6302024806202410-Q 6/30/2024
3312024507202410-Q 3/31/2024
12312023229202410-K 12/31/2023
93020231107202310-Q 9/30/2023
6302023808202310-Q 6/30/2023
3312023509202310-Q 3/31/2023
12312022301202310-K 12/31/2022
93020221109202210-Q 9/30/2022
6302022809202210-Q 6/30/2022
3312022510202210-Q 3/31/2022
12312021316202210-K 12/31/2021
93020211112202110-Q 9/30/2021

Insider Activity

Expand for More

 OwnerTitleFiling DateActionPriceSharesTransacted
Value		Value of
Held Shares		Form
0Langhans JarrodChief Financial Officer8192025Sell60.005,000300,0006,253,620Form
1Langhans JarrodChief Financial Officer8112025Sell51.185,000255,9005,590,238Form
2Fieldly JohnChief Executive Officer8082025Sell51.18143,1677,327,28745,827,084Form
3Milmoe William H.7302025Sell47.00100,0004,700,000842,135,190Form
4DeSantis Deborah7302025Sell47.00100,0004,700,000842,135,190Form

External Quote Links


Prefer one of these to Trefis? Tell us why.